You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 3, September 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Mitochondria-Lipid-Glycogen (MLG) Disease of Muscle

A Morphologically Regressive Congenital Myopathy

Felix Jerusalem, MD; Corrado Angelini, MD; Andrew G. Engel, MD; Robert V. Groover, MD

Arch Neurol. 1973;29(3):162-169.


Abstract

Muscle biopsies of a 7-week-old girl with profound weakness of all but the ocular muscles, combined with hypotonia, hyporeflexia, hepatomegaly, macroglossia, myopathic electromyogram, and slight elevation of serum enzyme levels revealed mild glycogen and marked lipid and mitochondrial excess. Glycogen structure and anaerobic glycolysis were normal. Aldolase and pyruvate kinase levels were relatively low and the lactic dehydrogenase isoenzyme pattern resembled that of heart muscle. Subsequently the patient had normal intellectual and delayed motor development and her macroglossia disappeared. At 22 months pathologic alterations in muscle were strikingly improved and glycolytic enzyme levels and oxidation of labeled oleic acid and Krebs cycle intermediates were normal. Although still unidentified, the basic metabolic lesion is one that (1) affects mitochondria! morphology, (2) alters lipid and glycogen metabolism, (3) may improve with age, and (4) is compatible with a benign clinical course after early infancy.



Author Affiliations

Rochester, Minn

From the Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Accepted for publication April 10, 1973.

Reprint requests to Department of Neurology, Mayo Clinic, Rochester, MN 55901 (Dr. Engel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Myopathy and Fatal Cardiopathy due to Cytochrome c Oxidase Deficiency
Zeviani et al.
Arch Neurol 1986;43:1198-1202.
ABSTRACT  

Lipid Storage Myopathy in Familial Hyperlipoproteinemia
Kinoshita and Wakata
Arch Neurol 1984;41:551-554.
ABSTRACT  

Familial Systemic Carnitine Deficiency
Cruse et al.
Arch Neurol 1984;41:301-305.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.